PubMed Central, : RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2024 April; 15(2): e0007. ISSN: 2076-9172Published online 2024 April 28. doi: 10.5041/RMMJ.10521

Table 3.

Uncontrolled Studies Published Before 1990 of the Outcomes of Cholecystectomy with Open Common Duct Exploration.

Author	Mean age y	Patients n	Stone Clearance n (%)^*	Additional CBDI Needed (ES or Surg.) n (%)^†	Complications n (%)^†	Mortality n (%)	Length of Hospital Stay d (range)
Way et al. (1972)²⁹	56.9	200	127/141 (90.1)	22/200 (11.0)	NG	5/200 (2.5)	NG

Stefanini et al. (1974)²⁸	56.6	712	NG	NG	14/712 (2.0)	7/712 (1.1)	NG

Vellacott and Powel (1979)³⁵	66	122	71/78 (92.2)	NG	11/122 (9.0)	9/122 (7.4)	16

Gaskill et al. (1982)²⁷	56	71	64/71 (90.1)	NG	21/71 (29.6)	2/71 (2.8)	13

Antrum and Hall (1984)³⁴	60.8	118	101/118 (85.6)	4/118 (3.4)	7/118 (5.9)	3/118 (2.5)	12

Crumplin et al. (1985)³³	60.4	160	84/95 (88.4)	5/160 (3.1)	73/160 (45.6)	4/160 (2.5)	16.2

Rogers et al. (1985)³²	60	100	46/55 (83.6)	3/100 (3.0)	NG	3/100 (3.0)	NG

Roukema et al (1986)³⁷	<70	657	514/557 (92.3)	42/1007 (4.2)	203/1007 (20.2)	6/657 (0.9)	NG
	70–79	266				7/266 (2.6)
	>80	84				8/84 (9.5)

Neoptolemos et al. (1987)⁹	57.9	248	212/238 (89.1)	26/248 (10.5)	56/248 (22.6)	10/248 (4.0)	NG

Sheridan et al. (1987)³⁰	57.4	257	163/200 (81.5)	22/257 (8.6)	118/257 (45.9)	5/257 (1.9)	15.6

Irvin and Arnstein (1988)³⁶	<70	77	75/77 (97.4)	NG	5/77 (7.0)	0/77 (0.0)	10.4
Irvin and Arnstein (1988)³⁶	>70	69	66/69 (95.7)	NG	12/69 (17.4)	2/69 (2.9)	13.4

Miller et al. (1988)¹⁴	58.0	81	76/81 (93.8)	5/81 (6.2)	13/81 (16.0)	1/81 (1.2)	10.3

Heinerman et al. (1989)¹⁰	56.3	78	65/78 (83.3)	12/78 (15.4)	17/78 (21.8)	3/78 (3.8)	NG

McEntee et al. (1989)³¹	59.4	164	160/164 (97.6)	NG	NG	1/164 (0.6)	NG

Miller and Ferguson (1990)¹⁵	NG	42	33/42 (78.6)	9/42 (21.4)	10/42 (23.8)	1/42 (2.4)	10.4

Pappas et al. (1990)²⁶	52.7	100	95/100 (95.0)	5/100 (5.0)	15/100 (15.0)	0/100 (0.0)	NG

Total	52–>80	3606	1952/2164 (90.2)	155/2391 (6.5)	575/3142 (18.3)	77/3606 (2.1)	10.3–16

* The denominators include the total number of patients entered into the trial, after excluding those with suspected but absent CBD stones.

† The denominators include the number of patients with available data.

CBDI, common bile duct interventions; d, day(s); NG, not given; y, year(s).